Loading...
Docoh

American Bio Medica (ABMC)

Employees
Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

At the Annual Meeting of the Shareholders of the Company held on June 24, 2021 (the “Annual Meeting”), at the Company’s corporate offices in Kinderhook, New York, the following matters were voted upon.

Total Shares in Attendance:25,562,751Total Shares Outstanding (as of April 27, 2021) 40,203,476
Percent of Shares Voted:63.6%



PROPOSAL NUMBER 1 – ELECTION OF DIRECTORS

Director For
Percent
Withheld
Percent
Broker Non-Votes





Peter Jerome 4,123,947 35% 7,658,978 65% 13,679,826
Melissa Waterhouse 3,363,301 28.5% 8,419,624 71.5% 13,679,826


In addition to the shares indicated above, there were 100,000 shares uncast for Proposal Number 1.


PROPOSAL NUMBER 2 – RATIFICATION OF AUDITORS

Percent
Against
Percent
Abstain
Percent
Broker Non-Votes
20,867,317 81.6% 4,692,397 18.4% 3,037 0.01% 0


PROPOSAL NUMBER 3 – APPROVAL OF AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON SHARES FROM 50,000,000 TO 75,000,000 COMMON SHARES

For
Percent
Against
Percent
Abstain
Percent
Broker Non-Votes
16,503,038 64.6% 8,976,835 35.1% 82,878 0.3% 0


A description of the proposals can be found in the Company’s definitive proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on May 4, 2021.

The nominees for election to the Board of Directors were each elected for a three-year term ending in 2024, or until their successor is elected and duly qualified. In addition to the directors elected at the Annual Meeting, Jean Neff continued her term of office after the Annual Meeting.

There were no other matters voted upon or discussed at the Annual Meeting other than the Proposals noted above.